<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1589">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04346420</url>
  </required_header>
  <id_info>
    <org_study_id>DTM-001</org_study_id>
    <nct_id>NCT04346420</nct_id>
  </id_info>
  <brief_title>Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19</brief_title>
  <official_title>Impact of the Double-Trunk Mask on Oxygenation Titration in Patients With COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the impact of the Double-Trunk Mask (DTM) on the reduction of
      oxygen titration in patients with severe hypoxemia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Double-Trunk Mask (DTM) is a device designed to increase the fraction of inspired oxygen
      in patients who receive oxygen therapy. The mask is composed of a regular aerosol mask with
      corrugated tubing (15 cm length) inserted into two lateral holes.

      Each included patient will wear standard nasal cannula in addition to the Double-Trunk Mask
      for 30 minutes, then only their standard oxygen interface for the next 30 minutes. While
      maintaining the oxygen saturation by pulse oximetry (SpO2) at a target value of 94%, the
      impact of the DTM will be assessed by measuring the change of oxygen flow given to the
      patient.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 9, 2020</start_date>
  <completion_date type="Actual">May 1, 2020</completion_date>
  <primary_completion_date type="Actual">May 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in O2 output</measure>
    <time_frame>At baseline and 30 minutes after wearing both systems</time_frame>
    <description>The O2 output will be adjusted to maintain a SpO2 of 94% using both systems for administering O2. The O2 flow will be read from the position of the ball in flow meters.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comfort with the interfaces</measure>
    <time_frame>30 minutes after wearing both systems</time_frame>
    <description>A Likert scale from 0 to 5 will be used to measure the subjective comfort of the patient while wearing the standard interface for administering O2 and/or the DTM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in PaO2</measure>
    <time_frame>At baseline and 30 minutes after wearing DTM</time_frame>
    <description>Oxygen tension (PaO2) in mmHg will be analyzed from a sample taken from the arterial system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in PaCO2</measure>
    <time_frame>At baseline and 30 minutes after wearing DTM</time_frame>
    <description>Carbon dioxide tension (PaCO2) in mmHg will be analyzed from a sample taken from the arterial system.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in pH</measure>
    <time_frame>At baseline and 30 minutes after wearing DTM</time_frame>
    <description>Potential of Hydrogen (pH) will be analyzed from a sample taken from the arterial system.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in respiratory rate</measure>
    <time_frame>At baseline and 30 minutes after wearing both systems</time_frame>
    <description>Respiratory rate is measured during one minute by visual inspection.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>COVID</condition>
  <condition>Hypoxemia</condition>
  <arm_group>
    <arm_group_label>O2 DTM+</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The standard nasal cannula interface is accompanied with the DTM</description>
  </arm_group>
  <arm_group>
    <arm_group_label>O2 DTM-</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The standard interface for administering oxygen (nasal cannula or oxygen mask) is worn by the patient, without the DTM</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard interface</intervention_name>
    <description>The standard interface for administering oxygen (nasal cannula or oxygen mask) is worn by the patient. Oxygen output is adapted to reach a SpO2 target of 94%.</description>
    <arm_group_label>O2 DTM-</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Double-Trunk Mask</intervention_name>
    <description>The standard nasal cannula interface accompanied with the DTM is worn by the patient. Oxygen output is adapted to reach a SpO2 target of 94%.</description>
    <arm_group_label>O2 DTM+</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COVID-19

          -  SpO2 between 92 and 96% with low-flow oxygen therapy (&lt; 15 L/min).

        Exclusion Criteria:

          -  Chronic obstructive pulmonary disease or other chronic respiratory disease

          -  Confusion

          -  Hypoxemia corrected (SpO2 ≥ 96%) with O2 flow ≤ 3 L/min

          -  Contra-indications to arterial blood gas sampling (peripheral arteriopathy, bleeding
             disorder)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cliniques universitaires Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <state>Brussels Capital</state>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 8, 2020</study_first_submitted>
  <study_first_submitted_qc>April 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2020</study_first_posted>
  <last_update_submitted>June 5, 2020</last_update_submitted>
  <last_update_submitted_qc>June 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</investigator_affiliation>
    <investigator_full_name>Poncin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

